Lv6
2850 积分 2023-02-18 加入
870-P: Long-Term Efficacy and Safety of Crisugabalin Besilate in Chinese patients with Diabetic Peripheral Neuropathic Pain
11天前
已完结
868-P: Efficacy and Safety of Crisugabalin with Acetyl-Levo-Carnitine in Chinese Patients with Diabetic Peripheral Neuropathic Pain—A Multicentre, Randomized, Open-Label, Positive-Controlled, Parallel-Group, Phase 2 Trial
11天前
已关闭
EP145 Efficacy and safety of crisugabalin for the treatment of perioperative analgesia in patients undergoing orthopedic surgery: a multi-centre, randomized, double-blind, placebo-controlled, phase 2 trial
11天前
已完结
Effect of polyethylene Glycol Loxenatide (long-acting GLP-1RA) on lipid, glucose levels and weight in type 2 diabetes mellitus patients with obesity
11天前
已完结
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
29天前
已完结
Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes
2个月前
已完结
Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world
2个月前
已完结
Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world
2个月前
已完结
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
3个月前
已完结
Glucagon-Like Peptide 1 (GLP-1) Receptor Variants and Glycemic Response to Liraglutide: A Pharmacogenetics Study in Iranian People with Type 2 Diabetes Mellitus
3个月前
已完结
皖公网安备34019202002308
